Q-omics provides the consensus-scored CTAGE14P profile across patient tissues and cancer cell-line models. CTAGE14P expression is associated with patient survival in 15 of 34 cancer types, with the highest sampling consensus in STAD. Among the 18 cancer types available for tumor–normal comparison, CTAGE14P is differentially expressed in 4, with the highest sampling consensus in READ. Additionally, CTAGE14P RNA expression shows 7,157 significant protein co-abundance associations, with the highest sampling consensus in CCRCC. Together, these results highlight STAD, READ, and CCRCC as cancer lineages where CTAGE14P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for CTAGE14P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes CTAGE14P survival associations across molecular data types. CTAGE14P RNA expression shows survival associations in the most cancer types (15). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible CTAGE14P RNA expression–survival associations across cancer types. High CTAGE14P expression shows unfavorable associations in STAD, UCS, DLBC, UVM and LIHC, but favorable associations in LUSC. The STAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .002). Together, the overview and detailed table identify STAD as the clearest survival context for CTAGE14P RNA expression.
This table summarizes CTAGE14P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 4. The strongest signals are observed in READ for RNA.
This table ranks reproducible tumor–normal expression differences for CTAGE14P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. CTAGE14P shows lower tumor expression in READ, COAD and LIHC and higher tumor expression in LUAD. The READ box plot shows higher CTAGE14P RNA expression in normal versus tumor tissue (log2 FC = −0.050, t-test p < 0.001).
This table shows molecular features associated with CTAGE14P in patient tissues and cancer cell lines. In patient samples, CTAGE14P shows the broadest associations at the RNA and protein expression levels, with CCRCC recurring as the lineage with the largest associated feature set.
